These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135 [TBL] [Abstract][Full Text] [Related]
25. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
26. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). Bidstrup BP; Royston D; Sapsford RN; Taylor KM J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457 [TBL] [Abstract][Full Text] [Related]
27. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery. Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607 [TBL] [Abstract][Full Text] [Related]
28. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations. Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944 [TBL] [Abstract][Full Text] [Related]
29. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451 [TBL] [Abstract][Full Text] [Related]
30. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of aprotinin in aortocoronary bypass and valve replacement operations: a placebo-controlled randomized double-blind study. Rodrigus IE; Vermeyen KM; De Hert SG; Amsel BJ; Walter PJ Perfusion; 1996 Jul; 11(4):313-8. PubMed ID: 8884859 [TBL] [Abstract][Full Text] [Related]
32. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Cosgrove DM; Heric B; Lytle BW; Taylor PC; Novoa R; Golding LA; Stewart RW; McCarthy PM; Loop FD Ann Thorac Surg; 1992 Dec; 54(6):1031-6; discussion 1036-8. PubMed ID: 1280411 [TBL] [Abstract][Full Text] [Related]
33. Re-graft patency and clinical efficacy of aprotinin in elective bypass surgery. Lass M; Simic O; Ostermeyer J Cardiovasc Surg; 1997 Dec; 5(6):604-7. PubMed ID: 9423946 [TBL] [Abstract][Full Text] [Related]
34. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery. Lindvall G; Sartipy U; Ivert T; van der Linden J Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391 [TBL] [Abstract][Full Text] [Related]
35. A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement, and myocardial injury in total arterial grafting. Taggart DP; Djapardy V; Naik M; Davies A J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1087-94. PubMed ID: 14566252 [TBL] [Abstract][Full Text] [Related]
36. The use of high doses of aprotinin to decrease blood loss in aortocoronary by-pass surgery. Dementieva II; Dzemeshkevich SL; Charnaya MA; Shabalkin BV J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):185-6. PubMed ID: 7539806 [TBL] [Abstract][Full Text] [Related]
37. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. Sedrakyan A; Treasure T; Elefteriades JA J Thorac Cardiovasc Surg; 2004 Sep; 128(3):442-8. PubMed ID: 15354106 [TBL] [Abstract][Full Text] [Related]
39. Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study. van der Meer J; Hillege HL; Ascoop CA; Dunselman PH; Mulder BJ; van Ommen GV; Pfisterer M; van Gilst WH; Lie KI Thromb Haemost; 1996 Jan; 75(1):1-3. PubMed ID: 8713770 [TBL] [Abstract][Full Text] [Related]
40. The efficacy and safety of aprotinin use in cardiac surgery. Rich JB Ann Thorac Surg; 1998 Nov; 66(5 Suppl):S6-11; discussion S25-8. PubMed ID: 9869434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]